Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.

The Central Board of Secondary Education (CBSE) is conducting the Class 12 board exams for the 2025 academic year. The Biotechnology exam for Class 12 is scheduled for March 21, 2025. Students can ...

Among the functions they perform are as storage compartments for biomolecules, facilitators of DNA repair and hubs of gene regulation ... The team studied a model condensate in vitro, made from a ...

Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic ... Tesaglitazar, a pparα/γ agonist, induces interstitial mesenchymal cell dna synthesis and fibrosarcomas in ...

Just like the government uses an Aadhaar number to uniquely identify an individual for social security purposes, a person’s DNA fingerprint can be used for biological purposes. This is why DNA ...

A new study suggests that severe trauma, like that experienced in war, can leave epigenetic “scars” on DNA that endures for generations. In the early 1980s, the Syrian regime carried out a ...

Geoff Bennett: The genetic testing company 23andMe has filed for bankruptcy. And its potential sale has raised alarms about what could happen to the DNA data of its millions of users. 23andMe was ...